References
- B. Cameron, P. Peduzzi, and D. Esserman, Extensions to the two-stage randomized trial design for testing treatment, self-selection, and treatment preference effects to binary outcomes, Stat. Med. 37 (2019), pp. 3147–3178. MR3853275.
- N.M. Clarks, N.K. Janz, J.A. Dodge, L. Mosca, X. Lin, Q. Long, and J. Liang, The effect of patient choice of intervention on health outcomes, Contemp. Clin. Trials 29 (2008), pp. 679–686.
- D. Collett, Modeling Survival Data in Medical Research, 2nd ed., Chapman & Hall/CRC, Baco Raton, Florida, 2003.
- M.R. Janevic, N.K. Janz, X.L. Dodge, W. Pan, B.R. Sinco, and N.M Clark, The role of choice in health education intervention trials: A review and case study, Soc. Sci. Med. 56 (2003), pp. 1581–1594.
- R. Jiang and D.N.P. Murthy, A study of Weibull shape parameter: Properties and significance, Reliab. Eng. Syst. Safety 96 (2011), pp. 1619–1626.
- Q. Long, R.J. Little, and X. Lin, Causal inference in hybrid intervention trials involving treatment choice, J. Am. Stat. Assoc. 103 (2008), pp. 474–484. MR2523986.
- T.P. Morris, I.R. White, and M.J. Crowther, Using simulation studies to evaluate statistical methods, Stat. Med. 38 (2019), pp. 2074–2102. MR3937487.
- R.W. Motl, D. Backus, W.N. Neal, G. Cutter, L. Palmer, R. McBurney, H. Schmidt, F. Bethoux, J. Hebert, A. Ng, K.K. McCully, and P. Plummer, Rationale and design of the STEP for MS trial: Comparative effectiveness of supervised versus telerehabilitation exercise programs for multiple sclerosis, Contemporary Clinical Trials 81 (2019), pp. 110–122.
- Y. Nilsagard, H.J. Gunn, and J. Freeman, Falls in people with MS–an individual data meta-analysis from studies from Australia, Sweden, United Kingdom and the United States, Multip. Scler. J. 21 (2015), pp. 92–100.
- S. Piantadosi, Clinical Trials: A Methodologic Perspective, 3nd ed., John Wiley and Sons, Inc., Hoboken, NJ, 2017.
- Patient Centered Outcomes Research Institute. (n.d) PCORI. https://www.pcori.org.
- G. Rücker, A two stage trial design for testing treatment, self-selection and treatment preference effects, Stat. Med. 8 (1989), pp. 477–485.
- Y. Shi, B. Cameron, X. Gu, M. Kane, P. Peduzzi, and D.A. Esserman, Two-stage randomized trial design for testing treatment, preference, and self-selection effects for count outcomes, Stat. Med. 39 (2020), pp. 3653–3683. MR4157860.
- D.J. Torgerson, J. Klaber-Moffett, and I.T. Russell, Patients preferences in randomized trials: Threat or opportunity? J. Health Serv. Res. Policy 1 (1996), pp. 194–197.
- T. Torsney-Weir, optim.function: Standard benchmark optimization functions [Computer software], R Core Team, 2013, http://www.R-project.org/.
- R.M. Turner, S.D. Walter, P. Macaskill, K.J. McCaffery, and L. Irwig, Sample size and power when designing a randomized trial for the estimation of treatment, selection, and preference effects, Med. Decis. Making 34 (2014), pp. 711–719.
- S.D. Walter, R.M. Turner, P. Macaskill, K.J. Mccaffery, and L. Irwig, Optimal allocation of participants for the estimation of selection, preference and treatment effects in the two-stage randomized trial design, Stat. Med. 31 (2012), pp. 1307–1322.